Drug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufacturing facility, with a Voluntary Action Indicated classification following a November 2025 inspection.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rp3wNg6
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(126)
-
▼
February
(67)
- Abbott signs pact with Novo Nordisk to offer semag...
- Lupin receives USFDA EIR for Goa facility with VAI...
- India moves closer to dengue vaccine as final tria...
- Dräger India collaborates with Breach Candy Hospit...
- Navigating environmental shifts: How proactive hyg...
- Alembic Pharma gets USFDA nod for generic drug
- Zydus plans launch of semaglutide generic in reusa...
- GST department initiates inspection and search ops...
- India’s weight-loss drugs to get cheaper as semagl...
- Dr Reddy's gearing up for March debut of generic s...
- Merck & Co to create a separate cancer unit as pat...
- Drug regulator cracks down hard on non-compliant c...
- Government urges pharma sector to anchor global su...
- India's drug regulator inspected 90% of cough syru...
- Biosimilars & innovation are Dr. Reddy’s growth pi...
- Expects Pen-G production capacity to touch 10k met...
- BahiaFarma, Biocon, Bionovis inks MoU in pharma se...
- Quality Care India plans to invest Rs 600 crore to...
- Novartis exits India arm, ChrysCapital-led group b...
- Drugmakers flag concerns over blue-strip antibioti...
- ChrysCapital, two others launch open offer for Nov...
- Indian drugmaker Sai Life Sciences to boost headco...
- Thyroid, antibiotic drugs face fresh safety warnin...
- Zydus launches biosimilar for ophthalmic care
- Pharma firms asked for side-effects of common medi...
- Warburg Pincus talks in final lap to buy Integrace...
- Steroid abuse among gym-goers raises heart, liver ...
- Seeing with sound: AIIMS distributes AI-powered sm...
- AI can address health inequities, but cannot repla...
- 29 vitamin-mineral FDC drugs under review for poss...
- Lupin signs supply deal to launch antidepressant i...
- Alkem Labs' Chakan facility gets six observations ...
- Govt looks to provide access to AI resources to me...
- Adven Biotech says it's India's first homeopathic ...
- GST rejig marks key shift towards making cancer ca...
- India becoming backbone of global clinical research
- Alkem Labs unit to buy up to 55% of Occlutech for ...
- AIIMS Delhi first in country to announce launch of...
- HUL turns ₹70 cr bet in Wellbeing Nutrition into ₹...
- Zydus settles US Mirabegron patent dispute with As...
- USV Pharma leads race to buy 85% stake in Wellbein...
- Trial by fire: Novelis may see bigger cash flow hit
- Zydus Life cleared to sell life-saving cancer drug...
- Warburg-Mubadala leads race to buy majority in Sof...
- French pharma giant Servier to invest €15 million ...
- IHH Healthcare, Fortis launch initiative to streng...
- AstraZeneca gets CDSCO nod to market cancer drug I...
- Lupin clears Mirabegron patent dispute with Astell...
- Decide on Piramal's Dahej plant in a week: Supreme...
- Sampre Nutrition arm to set up facility in Egypt
- Sun Pharma, Dr Reddy's & Lupin call for big push i...
- India expected to see surge in Parkinson's disease...
- Sun Pharma to stay disciplined on M&A, says Dilip ...
- Battle for cooking oil: Nutritionists reveal which...
- Strengthening the India-US medicines partnership i...
- Wipro seeks Schedule M exemption for Tumkur plant,...
- Shukra Pharma gets YEIDA LoI for Rs 600-crore faci...
- Alembic Pharmaceuticals gets USFDA nod for generic...
- Drug regulator steps up oversight on product chang...
- Sun Pharma to pump in Rs 500 cr in Assam manufactu...
- Biopharma Shakti: India targets China dependence, ...
- AstraZeneca gets CDSCO approval for Durvalumab in ...
- Medical gear firms told to 'promptly' flag adverse...
- US tariff cut to 18% to boost India’s medical devi...
- Budget relief on the label: Govt proposes to drop ...
- Lupin rolls out generic oncology drug in US market
- Budget 2026 gives biologics & biosimilars a major ...
-
▼
February
(67)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment